Thomas Boehm

Title: Innovations of Thomas Boehm in Pharmaceutical Formulations

Introduction

Thomas Boehm is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of therapies for inflammatory and autoimmune disorders. With a total of 3 patents, his work has the potential to impact many lives.

Latest Patents

One of Thomas Boehm's latest patents involves a liquid formulation comprising a GM-CSF neutralizing compound. This invention relates to aqueous formulations that include a compound neutralizing GM-CSF in concentrations of at least about 20 mg/ml, along with a tonicity modifier and a buffer. The composition is designed to be stable, ensuring the long-term storage of the compound. This formulation is intended for therapeutic use, particularly in treating inflammatory and autoimmune disorders, including allergic and psoriatic disorders, as well as arthritic and asthmatic conditions. Additionally, a kit comprising this formulation is also provided.

Career Highlights

Throughout his career, Thomas Boehm has worked with prominent companies in the pharmaceutical industry. He has been associated with Amgen Research (Munich) GmbH and Takeda GmbH, where he has contributed to various innovative projects. His expertise in the field has allowed him to develop formulations that address critical health issues.

Collaborations

Thomas Boehm has collaborated with notable professionals in his field, including Thomas Urbig and Wolfram Steinhilber. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Thomas Boehm's work in developing stable liquid formulations for therapeutic use showcases his dedication to advancing medical science. His contributions are significant in the fight against inflammatory and autoimmune disorders, and his patents reflect a commitment to improving patient care.